NO20000484L - Krystallinsk dibenzotiazepinderivat og anvendelse derav som et antipsykotisk middel - Google Patents

Krystallinsk dibenzotiazepinderivat og anvendelse derav som et antipsykotisk middel

Info

Publication number
NO20000484L
NO20000484L NO20000484A NO20000484A NO20000484L NO 20000484 L NO20000484 L NO 20000484L NO 20000484 A NO20000484 A NO 20000484A NO 20000484 A NO20000484 A NO 20000484A NO 20000484 L NO20000484 L NO 20000484L
Authority
NO
Norway
Prior art keywords
crystalline
füä1
ethylü
dibenzoäb
hydroxyethoxy
Prior art date
Application number
NO20000484A
Other languages
English (en)
Norwegian (no)
Other versions
NO20000484D0 (no
Inventor
Evan William Snape
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of NO20000484D0 publication Critical patent/NO20000484D0/no
Publication of NO20000484L publication Critical patent/NO20000484L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D281/16—[b, f]-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glass Compositions (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
  • Liquid Crystal Substances (AREA)
NO20000484A 1997-08-01 2000-01-31 Krystallinsk dibenzotiazepinderivat og anvendelse derav som et antipsykotisk middel NO20000484L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9716161.6A GB9716161D0 (en) 1997-08-01 1997-08-01 Process
PCT/GB1998/002260 WO1999006381A1 (en) 1997-08-01 1998-07-28 A crystalline dibenzothiazepine derivative and its use as an antipsychotic agent

Publications (2)

Publication Number Publication Date
NO20000484D0 NO20000484D0 (no) 2000-01-31
NO20000484L true NO20000484L (no) 2000-03-16

Family

ID=10816746

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000484A NO20000484L (no) 1997-08-01 2000-01-31 Krystallinsk dibenzotiazepinderivat og anvendelse derav som et antipsykotisk middel

Country Status (31)

Country Link
US (2) US6372734B1 (cs)
EP (2) EP1589008B1 (cs)
JP (2) JP2001512109A (cs)
KR (1) KR20010022241A (cs)
CN (1) CN1125058C (cs)
AT (2) ATE496037T1 (cs)
AU (1) AU739255B2 (cs)
BG (1) BG64796B1 (cs)
BR (1) BR9811061A (cs)
CA (1) CA2295792C (cs)
CY (2) CY2200161T2 (cs)
CZ (1) CZ299225B6 (cs)
DE (4) DE69841216D1 (cs)
EE (1) EE04550B1 (cs)
ES (2) ES2296568T3 (cs)
GB (2) GB9716161D0 (cs)
HU (1) HU228620B1 (cs)
ID (1) ID24219A (cs)
IL (1) IL133618A (cs)
MY (1) MY120999A (cs)
NO (1) NO20000484L (cs)
NZ (1) NZ501914A (cs)
PL (1) PL338384A1 (cs)
PT (2) PT1000043E (cs)
RU (1) RU2224754C2 (cs)
SI (2) SI1589008T1 (cs)
SK (1) SK287145B6 (cs)
TR (1) TR200000848T2 (cs)
TW (1) TW533207B (cs)
WO (1) WO1999006381A1 (cs)
ZA (1) ZA986904B (cs)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2000141A1 (en) * 2002-03-20 2008-12-10 Teva Pharmaceutical Industries Ltd. Methods for preparing crystalline quetiapine hemifumarate
EP1495008A1 (en) 2003-02-22 2005-01-12 Teva Pharmaceutical Industries Limited Synthesis of quetiapine and pharmaceutically acceptable salts thereof
WO2004078735A1 (en) * 2003-03-03 2004-09-16 Hetero Drugs Limited Novel polymorphs of quetiapine fumarate
WO2004089957A1 (en) 2003-04-07 2004-10-21 Hetero Drugs Limited A novel crystalline form of dorzolamide hydrochloride
ES2223294B2 (es) 2003-08-08 2005-10-01 Vita Cientifica, S.L. Procedimiento de preparacion de un compuesto farmaceuticamente activo.
US20060081361A1 (en) * 2004-09-13 2006-04-20 Gabbey Lawrence W Oil cooler with integral filter
WO2006035293A1 (en) * 2004-09-27 2006-04-06 Ranbaxy Laboratories Limited Polymorphic forms of quetiapine hemifumarate
GB0425729D0 (en) * 2004-11-23 2004-12-22 Pliva Res & Dev Ltd Heterocyclic compounds
WO2006056772A2 (en) * 2004-11-23 2006-06-01 Pliva Hrvatska D.O.O. Salts of quetiapine
ES2234447B1 (es) * 2005-03-07 2006-03-01 Union Quimico-Farmaceutica S.A. Procedimiento para la obtencion de un derivado de 11-(4-sustituido-1-piperazinil)dibenzo(b,f)(1,4)tiazepina.
JP2008502707A (ja) * 2005-04-14 2008-01-31 テバ ファーマシューティカル インダストリーズ リミティド クエチアピンフマレートの調製方法
US20070072840A1 (en) * 2005-05-30 2007-03-29 Pandya Bhargav Polymorphic forms of quetiapine
WO2007036599A1 (en) 2005-09-30 2007-04-05 Fermion Oy New crystallization process of quetiapine hemifumarate
WO2007048870A1 (en) * 2005-10-28 2007-05-03 Fermion Oy Quetiapine hemifumarate purification by crystallization
US8389510B2 (en) * 2005-11-18 2013-03-05 Astrazeneca Ab Crystalline forms
WO2007062338A2 (en) * 2005-11-18 2007-05-31 Astrazeneca Ab Solid formulations
EP1951258A4 (en) * 2005-11-18 2013-01-02 Astrazeneca Ab LIQUID FORMULATIONS
WO2007062336A2 (en) * 2005-11-18 2007-05-31 Astrazeneca Ab Salt forms
JP2009516706A (ja) * 2005-11-18 2009-04-23 アストラゼネカ・アクチエボラーグ 結晶形
CZ300451B6 (cs) * 2006-07-03 2009-05-20 Farmak, A. S. Zpusob prípravy solí 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanolu (quetiapinu) a jejich cištení
WO2008066620A2 (en) * 2006-10-20 2008-06-05 Concert Pharmaceuticals Inc. Dibenzothiazepine derivatives
ATE480227T1 (de) 2007-02-14 2010-09-15 Lesvi Laboratorios Sl Pharmazeutische zusammensetzungen mit quetiapinfumarat
WO2008121415A2 (en) * 2007-03-29 2008-10-09 Teva Pharmaceutical Industries Ltd. Improved process for preparing quetiapine fumarate
US8101597B2 (en) * 2007-05-07 2012-01-24 Actavis Group Ptc Ehf Quetiapine salts and their polymorphs
US20090082334A1 (en) * 2007-09-25 2009-03-26 Protia, Llc Deuterium-enriched quetiapine
JP5385299B2 (ja) * 2007-12-05 2014-01-08 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ジベンゾアゼピンおよびジベンゾオキサゼピン・ｔｒｐａ１アゴニスト
EA018638B1 (ru) 2008-08-01 2013-09-30 Крка, Товарна Здравил, Д. Д., Ново Место Композиция кветиапина
WO2010033270A1 (en) * 2008-09-17 2010-03-25 Auspex Pharmaceuticals, Inc. Dibenzothiazepine modulators of dopamine, alpha adrenergic, and serotonin receptors
WO2010100623A1 (en) 2009-03-04 2010-09-10 Ranbaxy Laboratories Limited Process for the preparation of quetiapine fumarate
JP6096774B2 (ja) 2011-08-12 2017-03-15 キアゲン ゲゼルシャフト ミット ベシュレンクテル ハフツング 核酸を単離するための方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE787249A (fr) 1971-08-05 1973-02-05 Squibb & Sons Inc Derives amino d'acides pyrazolopyridine carboxyliques, leurs esters et les sels de ces composes, ainsi que leurs procedes de preparation
GB8607684D0 (en) * 1986-03-27 1986-04-30 Ici America Inc Thiazepine compounds
GB8705574D0 (en) * 1987-03-10 1987-04-15 Ici Plc Preparation of thiazepine compound

Also Published As

Publication number Publication date
ES2296568T1 (es) 2008-05-01
ID24219A (id) 2000-07-13
EE200000062A (et) 2000-10-16
ATE444959T1 (de) 2009-10-15
ATE496037T1 (de) 2011-02-15
EP1000043B1 (en) 2009-10-07
HK1081962A1 (en) 2006-05-26
DE05011169T1 (de) 2008-11-06
PT1000043E (pt) 2009-11-30
PL338384A1 (en) 2000-10-23
NZ501914A (en) 2001-09-28
ES2296575T3 (es) 2010-02-05
MY120999A (en) 2005-12-30
SK287145B6 (sk) 2010-01-07
CN1265101A (zh) 2000-08-30
GB9814882D0 (en) 1998-09-09
SI1589008T1 (sl) 2011-04-29
EP1589008A1 (en) 2005-10-26
TW533207B (en) 2003-05-21
HU228620B1 (en) 2013-04-29
US6372734B1 (en) 2002-04-16
IL133618A (en) 2004-02-08
IL133618A0 (en) 2001-04-30
EP1589008B1 (en) 2011-01-19
SK1302000A3 (en) 2000-06-12
WO1999006381A1 (en) 1999-02-11
CY2200162T2 (el) 2010-07-28
EE04550B1 (et) 2005-10-17
JP2009102345A (ja) 2009-05-14
ES2296568T3 (es) 2011-05-06
KR20010022241A (ko) 2001-03-15
BG104176A (en) 2000-08-31
HK1029992A1 (en) 2001-04-20
CN1125058C (zh) 2003-10-22
GB9716161D0 (en) 1997-10-08
DE69842104D1 (de) 2011-03-03
BG64796B1 (bg) 2006-04-28
RU2224754C2 (ru) 2004-02-27
AU739255B2 (en) 2001-10-04
CA2295792C (en) 2007-04-17
CY2200161T2 (el) 2010-07-28
AU8549898A (en) 1999-02-22
DE98936529T1 (de) 2008-11-20
CZ299225B6 (cs) 2008-05-21
CA2295792A1 (en) 1999-02-11
HUP0002663A3 (en) 2001-10-29
BR9811061A (pt) 2000-09-19
ES2296575T1 (es) 2008-05-01
DE69841216D1 (de) 2009-11-19
JP2001512109A (ja) 2001-08-21
EP1000043A1 (en) 2000-05-17
HUP0002663A2 (hu) 2001-09-28
PT1589008E (pt) 2011-03-23
ZA986904B (en) 1999-02-01
CZ2000341A3 (cs) 2000-05-17
US20020147186A1 (en) 2002-10-10
TR200000848T2 (tr) 2000-08-21
NO20000484D0 (no) 2000-01-31
SI1000043T1 (sl) 2010-01-29

Similar Documents

Publication Publication Date Title
NO20000484L (no) Krystallinsk dibenzotiazepinderivat og anvendelse derav som et antipsykotisk middel
AU697679B2 (en) Treatment of tinnitis using neuroprotective agents
FI20031381A7 (fi) Menetelmä antihistamiinisten 4-difenyylimetyylipiperidiinijohdannaisten valmistamiseksi
AU6350699A (en) Chemical compounds
MY114393A (en) 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1, 3-propanediol derivatives
NO931534L (no) Sulfonylbenzylsubstituerte benzo- og pyridopyridoner
NO303641B1 (no) Optisk aktive benzotiepinderivater, mellomprodukter for deres fremstilling og deres anvendelse
FI962639A0 (fi) Diaryyli-5,6-fuusioituneita heterosyklisiä happoja leukotrieeniantagonisteina
NO980923D0 (no) Optisk aktivt fenylpyrimidin-derivat som analgetisk middel
DK1075471T3 (da) Idolylderivater som serotonerge midler
AU4009497A (en) Substituted pyrazolyl-pyrazole derivatives, process for their preparation nd their use as agents with a herbicidal effect
ES2091285T3 (es) 2-hidroxi-1,2,3-propanotricarboxilato de 3-((5-metil-2-furanil)-metil)-n-(4-piperidinil)-3h-imidazo-(4,5-b)-piridin-2-amina.
DK1181290T3 (da) Polymorfer af et krystallinsk azabicyclo[2,2,2]octan-3-amin-citrat samt deres farmaceutiske præparater
PT1019521E (pt) Um metodo para a biotransformacao de compostos de colchicona nos derivados de 3-glicosil correspondentes
AU638829B2 (en) Composition for disinfecting water by the electrochlorination process and use of this composition
DK0789658T3 (da) Styreindretning til at opnå optimal anvendelse af den energi, der frembringes af et fartøjs hovedenergikilde
AU7379794A (en) Aza-5,5-fused heterocyclic acids as leukotriene antagonists
AU2002339219A1 (en) Improved process for the preparation of optically active phenoxazine derivatives as antidiabetic agents
IT9022077A0 (it) Procedimento per il recupero dei residui stirenici solforati.
IT236181Y1 (it) Punta perfezionata per chirurgia oculistica,in particolare per larimozione della cataratta
SE9602476D0 (sv) Process for the preparation of organic salts of N'N -diacetylcystine
SE9602418D0 (sv) Process for the preparation of organic salts of N'N-diacetylcystine
ITRM940839A0 (it) "cerotto per assorbimento transcutaneo a rilascio controllato di fitoassociazione eventualmente arricchita"